1. Home
  2. SHEN vs EVO Comparison

SHEN vs EVO Comparison

Compare SHEN & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shenandoah Telecommunications Co

SHEN

Shenandoah Telecommunications Co

HOLD

Current Price

$14.16

Market Cap

895.1M

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.57

Market Cap

994.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHEN
EVO
Founded
1902
1993
Country
United States
Germany
Employees
N/A
4553
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
895.1M
994.5M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
SHEN
EVO
Price
$14.16
$2.57
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$26.00
$7.00
AVG Volume (30 Days)
266.7K
28.6K
Earning Date
05-01-2026
04-08-2026
Dividend Yield
0.73%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$357,854,000.00
N/A
Revenue This Year
$7.12
$1.37
Revenue Next Year
N/A
$10.05
P/E Ratio
N/A
N/A
Revenue Growth
9.08
N/A
52 Week Low
$9.67
$2.31
52 Week High
$17.35
$4.42

Technical Indicators

Market Signals
Indicator
SHEN
EVO
Relative Strength Index (RSI) 29.64 37.20
Support Level $14.10 $2.32
Resistance Level $14.47 $3.82
Average True Range (ATR) 0.64 0.07
MACD -0.21 -0.03
Stochastic Oscillator 5.57 0.00

Price Performance

Historical Comparison
SHEN
EVO

About SHEN Shenandoah Telecommunications Co

Shenandoah Telecommunications Co with its subsidiaries, provides various broadband communication products and services via its wireless, cable, fiber optic, and fixed wireless networks to customers in the Mid-Atlantic United States. The company operates through one business unit: Broadband. The broadband segment provides broadband Internet, video, and voice services to residential and commercial customers. The broadband segment generates the vast majority of the company's revenue, with the bulk of sales flowing from residential and small, and medium businesses within the broadband unit.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: